Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial.
Armstrong AJ, Clarke N, Oya M, Procopio G, de Menezes J, Guedes JD, Ghatalia P, Nolè F, Din O, Spiegelhalder P, Mincik I, van Alphen R, Lumen N, Hosius C, Zhou D, Barker L, Dujka M, Saad F.
Armstrong AJ, et al. Among authors: barker l.
Eur Urol Oncol. 2023 Oct 27:S2588-9311(23)00218-3. doi: 10.1016/j.euo.2023.10.004. Online ahead of print.
Eur Urol Oncol. 2023.
PMID: 39492050
Free article.